WCN26-5049 NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) AND HUMAN LEUKOCYTE ANTIGEN (HLA) TYPING IN KIDNEY TRANSPLANT

Read full text Summarise with VIRAT
Authors: Usama Alanan
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Neutrophil gelatinase-associated lipocalin (NGAL) is a protein released by kidney tubular cells in response to ischemia and can serve as an early indicator of conditions such as immunological rejection, calcineurin inhibitor toxicity, obstructive nephropathy, subclinical tubulitis, or infection. In the management of kidney transplant recipients (KTRs), NGAL is emerging as a significant biomarker. Elevated levels of urinary or serum NGAL shortly after transplantation are predictive of delayed graft function and are associated with diminished graft performance within a year.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Acute Kidney Injury Research Transplantation: Methods and Outcomes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105490–105490
Publication date
25 March 2026
Language
EN